Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai

BACKGROUND: There is very limited data on the experience and outcome of multidrug-resistant tuberculosis (MDR-TB) patients treated privately out of the DOTS plus program. Goal of this study is to provide characteristics and treatment outcomes of a prospective cohort of MDR-TB patients managed at a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Udwadia, Zarir F., Moharil, Gautam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220314/
https://www.ncbi.nlm.nih.gov/pubmed/25378840
http://dx.doi.org/10.4103/0970-2113.142101
_version_ 1782342712521916416
author Udwadia, Zarir F.
Moharil, Gautam
author_facet Udwadia, Zarir F.
Moharil, Gautam
author_sort Udwadia, Zarir F.
collection PubMed
description BACKGROUND: There is very limited data on the experience and outcome of multidrug-resistant tuberculosis (MDR-TB) patients treated privately out of the DOTS plus program. Goal of this study is to provide characteristics and treatment outcomes of a prospective cohort of MDR-TB patients managed at a private tertiary referral institute. MATERIALS AND METHODS: A prospective analysis of a cohort of MDR-TB patients treated in a tertiary private hospital, with the back-up of a Level 2 mycobacterial laboratory, which has recently received recognition by the Revised National Tuberculosis Control Program (RNTCP) for second-line drug susceptibility (DST). All patients received an individualized MDR regimen on an ambulatory basis. RESULTS: Our 68% success rates are respectable and show that given the right laboratory backing, MDR-TB can be managed successfully in selected private practice settings.
format Online
Article
Text
id pubmed-4220314
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42203142014-11-06 Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai Udwadia, Zarir F. Moharil, Gautam Lung India Original Article BACKGROUND: There is very limited data on the experience and outcome of multidrug-resistant tuberculosis (MDR-TB) patients treated privately out of the DOTS plus program. Goal of this study is to provide characteristics and treatment outcomes of a prospective cohort of MDR-TB patients managed at a private tertiary referral institute. MATERIALS AND METHODS: A prospective analysis of a cohort of MDR-TB patients treated in a tertiary private hospital, with the back-up of a Level 2 mycobacterial laboratory, which has recently received recognition by the Revised National Tuberculosis Control Program (RNTCP) for second-line drug susceptibility (DST). All patients received an individualized MDR regimen on an ambulatory basis. RESULTS: Our 68% success rates are respectable and show that given the right laboratory backing, MDR-TB can be managed successfully in selected private practice settings. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4220314/ /pubmed/25378840 http://dx.doi.org/10.4103/0970-2113.142101 Text en Copyright: © Lung India http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Udwadia, Zarir F.
Moharil, Gautam
Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
title Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
title_full Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
title_fullStr Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
title_full_unstemmed Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
title_short Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
title_sort multidrug-resistant-tuberculosis treatment in the indian private sector: results from a tertiary referral private hospital in mumbai
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220314/
https://www.ncbi.nlm.nih.gov/pubmed/25378840
http://dx.doi.org/10.4103/0970-2113.142101
work_keys_str_mv AT udwadiazarirf multidrugresistanttuberculosistreatmentintheindianprivatesectorresultsfromatertiaryreferralprivatehospitalinmumbai
AT moharilgautam multidrugresistanttuberculosistreatmentintheindianprivatesectorresultsfromatertiaryreferralprivatehospitalinmumbai